Results 121 to 130 of about 17,282 (158)

Cannabidiol reduces LPS-induced inflammatory response in the human placenta by reducing NF-κB translocation. [PDF]

J Cannabis Res
Portillo R, Synova T, Ghaddar MR, Alsouki MS, Kumnova F, Machacek M, Karahoda R, Abad C, Staud F.   +8 more
europepmc   +1 more source

Special Issue: Therapeutic Potential for Cannabis and Cannabinoids 2.0. [PDF]

Biomedicines
Raup-Konsavage WM.
europepmc   +1 more source

Medical Cannabis for Best Supportive Care of Patients Affected by Cancers of the Head and Neck: A Narrative Review. [PDF]

In Vivo
Perri F, Marciano ML, Zotta A, Pontone M, Piccirillo A, Casale M, DI Filippo P, Sarno MR, D' Aniello R, Cascella M, Maiolino P.   +10 more
europepmc   +1 more source

Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies. [PDF]

Diseases
Afonso S, Gonçalves J, Brinca AT, Rosendo LM, Rosado T, Duarte AP, Gallardo E.   +6 more
europepmc   +1 more source

The endocannabinoid system as a therapeutic target in intestinal fibrosis. [PDF]

Front Pharmacol
Misztal Z, Kaśniewska-Kosińska A, Wołyniak M, Małecka-Wojciesko E, Fabisiak A.   +4 more
europepmc   +1 more source

Cannabidiol in pancreatic ductal adenocarcinoma: preclinical evidence, molecular mechanisms, and translational challenges. [PDF]

Cancer Cell Int
Esmaeli M, Dehghanpour Dehabadi M, Khaleghi AA.   +2 more
europepmc   +1 more source

Editorial: Neurobiological basis of substance use disorders: new findings and perspectives. [PDF]

Front Neurosci
Favoretto CA, Loss CM, Vozella V, Cruz FC.   +3 more
europepmc   +1 more source

A Novel Approach for the Synthesis of Peripherally Acting Dual Target Inhibitor of Cannabinoid-1 (CB1 Receptor) and Inducible Nitric Oxide Synthase (iNOS) (<i>S</i>-MRI-1867/Zevaquenabant). [PDF]

Molecules
Iyer MR.
europepmc   +1 more source